CytoMed Therapeutics Limited - Ordinary Shares (GDTC) SEC filings
GDTC SEC filings moved a median of -0.84% by the close. GDTC SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the GDTC overview →
44 measured GDTC SEC filing events.
Where these GDTC SEC filings landedvs 43 measured GDTC SEC filing reactions
| Middle 50% of GDTC SEC filing reactions | -2.16% to +1.24% |
|---|---|
| Median reaction (to close) | -0.84% |
| Measured reactions | 43 |
Point-in-time · zero look-ahead
Half of the 43 GDTC SEC filing events with a measured close landed between -2.16% and +1.24%; 37% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 6-K CytoMed Therapeutics For: Oct 09 | SEC filing · Form 6-K | — | +5.33% | |
| Form 6-K CytoMed Therapeutics For: Jun 30 | SEC filing · Form 6-K | +3.11% | +6.59% | |
| Form 6-K CytoMed Therapeutics For: Jun 23 | SEC filing · Form 6-K | — | +1.41% | |
| Form 6-K CytoMed Therapeutics For: Jun 03 | SEC filing · Form 6-K | +0.00% | -0.84% | |
| Form 6-K CytoMed Therapeutics For: May 15 | SEC filing · Form 6-K | +1.90% | +22.12% | |
| Form 6-K CytoMed Therapeutics For: May 11 | SEC filing · Form 6-K | +0.00% | -0.12% | |
| Form 6-K CytoMed Therapeutics For: Apr 14 | SEC filing · Form 6-K | -0.99% | -1.01% | |
| Form 20-F CytoMed Therapeutics For: Dec 31 | SEC filing · Form 20-F | +0.00% | -1.96% | |
| Form 6-K CytoMed Therapeutics For: Mar 31 | SEC filing · Form 6-K | — | -1.96% | |
| Form 6-K CytoMed Therapeutics For: Jan 28 | SEC filing · Form 6-K | — | +5.53% | |
| Form 6-K CytoMed Therapeutics For: Jan 13 | SEC filing · Form 6-K | -2.32% | -11.59% | |
| Form 6-K CytoMed Therapeutics For: Dec 08 | SEC filing · Form 6-K | +2.58% | +2.78% | |
| Form 6-K CytoMed Therapeutics For: Nov 18 | SEC filing · Form 6-K | -4.52% | -1.00% | |
| Form 6-K CytoMed Therapeutics For: Nov 06 | SEC filing · Form 6-K | +20.95% | -19.37% | |
| Form 6-K CytoMed Therapeutics For: Oct 22 | SEC filing · Form 6-K | -1.05% | -6.62% | |
| Form 6-K CytoMed Therapeutics For: Oct 14 | SEC filing · Form 6-K | -4.46% | +0.45% | |
| Form 6-K CytoMed Therapeutics For: Oct 02 | SEC filing · Form 6-K | +0.00% | -0.98% | |
| Form 6-K CytoMed Therapeutics For: Jun 30 | SEC filing · Form 6-K | +0.00% | +0.51% | |
| Form 6-K CytoMed Therapeutics For: Aug 28 | SEC filing · Form 6-K | — | +2.04% | |
| Form 6-K CytoMed Therapeutics For: Aug 18 | SEC filing · Form 6-K | — | — | |
| Form 6-K CytoMed Therapeutics For: Jul 21 | SEC filing · Form 6-K | +0.00% | -4.76% | |
| Form 6-K CytoMed Therapeutics For: Jul 03 | SEC filing · Form 6-K | — | +4.69% | |
| Form EFFECT CytoMed Therapeutics | SEC filing · Form EFFECT | — | +3.93% | |
| Form F-3 CytoMed Therapeutics | SEC filing · Form F-3 | — | -1.42% | |
| Form 6-K CytoMed Therapeutics For: May 16 | SEC filing · Form 6-K | — | -3.66% | |
| Form 20-F CytoMed Therapeutics For: Dec 31 | SEC filing · Form 20-F | — | +1.28% | |
| Form 6-K CytoMed Therapeutics For: Apr 28 | SEC filing · Form 6-K | — | +1.28% | |
| Form 6-K CytoMed Therapeutics For: Jan 06 | SEC filing · Form 6-K | -12.18% | -12.94% | |
| Form S-8 CytoMed Therapeutics | SEC filing · Form S-8 | -4.17% | -5.13% | |
| Form 6-K CytoMed Therapeutics For: Dec 05 | SEC filing · Form 6-K | +0.00% | -3.01% | |
| Form 6-K CytoMed Therapeutics For: Nov 20 | SEC filing · Form 6-K | +0.00% | +0.92% | |
| Form 6-K CytoMed Therapeutics For: Oct 07 | SEC filing · Form 6-K | -1.45% | +1.21% | |
| Form 6-K CytoMed Therapeutics For: Oct 03 | SEC filing · Form 6-K | +0.56% | -0.92% | |
| Form 6-K CytoMed Therapeutics For: Sep 30 | SEC filing · Form 6-K | +0.63% | -0.63% | |
| Form 6-K/A CytoMed Therapeutics For: Jun 24 | SEC filing · Form 6-K | -0.24% | -0.48% | |
| Form 6-K CytoMed Therapeutics For: Jun 20 | SEC filing · Form 6-K | — | +0.00% | |
| Form 6-K CytoMed Therapeutics For: May 24 | SEC filing · Form 6-K | +0.48% | -1.09% | |
| Form 6-K/A CytoMed Therapeutics For: Apr 25 | SEC filing · Form 6-K | +0.00% | +0.00% | |
| Form 6-K CytoMed Therapeutics For: Apr 24 | SEC filing · Form 6-K | — | +0.46% | |
| Form 20-F CytoMed Therapeutics For: Dec 31 | SEC filing · Form 20-F | — | -3.59% | |
| Form 6-K CytoMed Therapeutics For: Mar 18 | SEC filing · Form 6-K | -0.44% | -0.88% | |
| Form 6-K CytoMed Therapeutics For: Mar 04 | SEC filing · Form 6-K | +0.00% | -1.41% | |
| Form 6-K CytoMed Therapeutics For: Jan 29 | SEC filing · Form 6-K | — | -2.41% | |
| Form 6-K CytoMed Therapeutics For: Jun 30 | SEC filing · Form 6-K | — | -2.36% |
Keep exploring
More GDTC: earnings → · analyst actions → · GDTC overview →